Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T)

NACompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

February 20, 2024

Conditions
Hospitalization
Interventions
DEVICE

continuous wireless monitoring system of Vital Signs (Win@Hospital) + continuous system for continuous monitoring of blood sugar (Dexcom G6)(only for diabetic patients)

Patients randomized to the experimental group on discharge or with transfer to the subacute ward will be connected to the system continuous monitoring of Vital Signs(Win@Hospital) continuous system for the continuous monitoring of blood sugar(Dexcom G6)(only for diabetic patients). The system, once applied, does not require the presence of a dedicated person and continuous monitoring in real time. It is set with alerts that are triggered both when the parameters they leave the normal ranges both if the data is not recorded due to technical problems. the data is transmitted in real time on mobile devices in the possession of a doctor and a nurse available 24 hours a day who guarantee the remote control system. Devices. Mobiles also contain the clinical information of each patient.

Trial Locations (1)

Unknown

Ospedale di Albano - Polo H2, Roma

All Listed Sponsors
lead

Fadoi Foundation, Italy

OTHER

NCT06293768 - Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T) | Biotech Hunter | Biotech Hunter